Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist is a equity ETF from Amundi tracking the UK Equity All Cap index through physical replication. Domiciled in Luxembourg and launched in 2018, the fund manages about 1 bn € and charges a TER of 0.04% — 4 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist competes with 44 other products in the same class and region (Equity, United Kingdom): it ranks 8th by fund size and 1st by ongoing cost, with a TER of 0.04% against a group median of 0.20%. It has been listed since 2018, 8 years of track record.
On a €10,000 investment the TER costs 4 € a year, against 20 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 47.0% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| HSBC Holdings PLC | 9.3% |
| AstraZeneca PLC | 8.3% |
| Shell plc | 6.2% |
| Rolls-Royce Holdings PLC | 4.5% |
| British American Tobacco PLC | 3.9% |
| Unilever PLC | 3.7% |
| GSK plc | 3.0% |
| Rio Tinto PLC | 2.9% |
| BP PLC | 2.7% |
| Barclays PLC | 2.5% |
| XETRA | LCUK | EUR |
| Francoforte | LCUK | EUR |
| London Stock Exchange | LCUK | GBP |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.